title: Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer.
abstract: OBJECTIVE
  To study bystander demyelination in multiple sclerosis with an experimental in vivo model of toxic demyelination.
  
  
  METHODS
  Toxic demyelinating lesions were created in two monkeys by injection of lysophosphatidylcholine in the centrum semiovale. Follow-up was done clinically and with serial MR studies, including T2-weighted and gadolinium-enhanced T1-weighted images and measurement of magnetization transfer ratio, until the animals were killed at days 14 and 34, respectively. Light and electron microscopy analysis was compared with MR data.
  
  
  RESULTS
  Interval measurement of magnetization transfer ratio during the course of the experiment revealed a maximum decrease at day 7 to day 8, associated with the greatest clinical manifestations. The lowest values of magnetization transfer ratio correlated with histopathologic findings of myelin and axon destruction. Magnetization transfer ratio measurements appear to be sensitive to macromolecular destruction and specifically to membrane disorganization. At no time was gadolinium enhancement observed in this model of toxic demyelination.
  
  
  CONCLUSIONS
  Preliminary results of this study indicated that magnetization transfer is a good technique to follow in vivo matrix destruction in brain parenchyma lesions. The results suggest also that phases of toxic demyelination in multiple sclerosis might not show gadolinium enhancement. Differentiation between demyelinating activity and associated inflammation in multiple sclerosis lesions should be considered in further in vivo work.
authors.affiliation: Department of Neuroradiology, Hospital Pellegrin, University of Bordeaux II, France.
authors.forename: V
authors.initials: V
authors.lastname: Dousset
authors.forename: B
authors.initials: B
authors.lastname: Brochet
authors.forename: A
authors.initials: A
authors.lastname: Vital
authors.forename: C
authors.initials: C
authors.lastname: Gross
authors.forename: A
authors.initials: A
authors.lastname: Benazzouz
authors.forename: A
authors.initials: A
authors.lastname: Boullerne
authors.forename: A M
authors.initials: AM
authors.lastname: Bidabe
authors.forename: A M
authors.initials: AM
authors.lastname: Gin
authors.forename: J M
authors.initials: JM
authors.lastname: Caille
mesh_terms: D000818:Animals; D001921:Brain / Q000473:pathology*; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D008244:Lysophosphatidylcholines; D008252:Macaca fascicularis; D008279:Magnetic Resonance Imaging; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis
chemical_list: D008244:Lysophosphatidylcholines